TKPHF - Takeda Pharmaceutical Co Ltd (TAK) CEO Christophe Weber on Q3 2021 Results - Earnings Call Transcript
Takeda Pharmaceutical Co Ltd (TAK) Q3 2021 Earnings Conference Call February 04, 2021, 06:00 ET Company Participants Christopher O'Reilly - Global Head, IR & Global Finance Christophe Weber - President & CEO Andrew Plump - President, Research & Development and Director Constantine Saroukos - CFO & Director Masato Iwasaki - President, Japan Pharma Business Unit & Director Julie Kim - President, Plasma-Derived Therapies Business Unit Ramona Sequeira - President, US Business Unit & Global Portfolio Commercialization Conference Call Participants Hidemaru Yamaguchi - Citigroup Shinichiro Muraoka - Morgan Stanley Fumiyoshi Sakai - Crédit Suisse Seiji Wakao - JPMorgan Chase & Co. Stephen Barker - Jefferies Stacy Ku - Cowen and Company Presentation Operator Good day, and welcome to the conference call of Takeda Pharmaceutical Company Limited. [Operator Instructions]. Now we'll start the conference. Mr. O'Reilly, please go ahead. Christopher O'Reilly Thank you very much for your participation in this conference call
For further details see:
Takeda Pharmaceutical Co Ltd (TAK) CEO Christophe Weber on Q3 2021 Results - Earnings Call Transcript